Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01EKS
|
|||
| Drug Name |
Acyl piperidine derivative 3
|
|||
| Synonyms |
PMID26560530-Compound-45
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
ASTON UNIVERSITY
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C19H28BrN3O3
|
|||
| Canonical SMILES |
C1CN(CCN1C(=O)CNC(=O)CBr)C(=O)C23CC4CC(C2)CC(C4)C3
|
|||
| InChI |
1S/C19H28BrN3O3/c20-11-16(24)21-12-17(25)22-1-3-23(4-2-22)18(26)19-8-13-5-14(9-19)7-15(6-13)10-19/h13-15H,1-12H2,(H,21,24)
|
|||
| InChIKey |
SCSKGYPISIGLDU-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Tissue transglutaminase (TG2) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Tissue transglutaminase (TG2) | Target's Patent Info | [1] | |
| KEGG Pathway | Huntington's disease | |||
| Pathway Interaction Database | Beta1 integrin cell surface interactions | |||
| Thromboxane A2 receptor signaling | ||||
| Alpha9 beta1 integrin signaling events | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Transglutaminase inhibitors: a patent review.Expert Opin Ther Pat. 2016;26(1):49-63. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.